Tokyo, Aug. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062448) titled 'A Comparison of the Incidence of Postdischarge Nausea and Vomiting' on Aug.... Read More
Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062597) titled 'Advance Care Planning Workshop for Adult Children of Elderly Parents' on Au... Read More
Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062594) titled 'A study of the effects of light touch on standing balance in older adults' ... Read More
Tokyo, Aug. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062591) titled 'Effect of Intermittent Leg Fidgeting on Daily Time in Tight Range (TITR) in... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More
Singapore, Aug. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More